Consolidated Statement of Cash Flows - USD ($)	12 Months Ended
	Jan. 31, 2021	Jan. 31, 2020
Cash flows from operating activities:
Net loss	$ (106,317)	$ (1,866,630)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and impairment	18,241	4,423
Written-off uncollected loan receivable		100,000
Written-off uncollected interest receivable		27,833
Litigation (income)	(1,337,252)
Stock based compensation	73,000
Changes in operating assets and liabilities:
Bad debt	9,691
Interest receivable		(9,000)
Accounts receivable	13,750	(23,441)
Accounts receivable, related party
Prepaid expenses	32,992	(4,865)
Increase (decrease) in accounts payable and accrued expenses	521,324	659,554
Increase (decrease) in related party payables	386,276	324,984
Net cash used in operating activities	(388,295)	(787,142)
Cash Flows from Investing Activities:
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from related party loans	395,325	795,910
Notes payable	(5,000)	(7,500)
Net cash provided by financing activities	390,325	788,410
Net decrease in cash	2,030	1,268
Cash-beginning of period	2,877	1,609
Cash-end of period	4,907	2,877
SUPPLEMENTAL DISCLOSURES
Interest paid
Income taxes paid
Non-cash Investing and Financing Activities:
Notes payable, short-term, related party offset by share purchase agreement	250,000
Notes payable, long-term add as part of litigation expense	350,000
Shares issued as part of litigation expense	22,400
Notes payable, short-term cancelled as part of litigation income	1,500,000
Accrued interest cancelled as part of litigation income	716,155
Accounts payable under litigation expense	$ 506,502